<DOC>
	<DOCNO>NCT01791140</DOCNO>
	<brief_summary>This observational study evaluate efficacy safety Avastin ( bevacizumab ) combination fluoropyrimidine-based chemotherapy elderly patient ( &gt; /= 65 year age ) newly diagnose metastatic colorectal cancer . Patients follow disease progression , death , withdrawal consent , discontinuation physician-patient relationship study closure , whichever come first .</brief_summary>
	<brief_title>BEVERLY-C : An Observational Study Avastin ( Bevacizumab ) First-Line Treatment Elderly Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Adult patient , &gt; /= 65 year age Patients newly diagnose metastatic colorectal cancer start firstline treatment Avastin combination fluoropyrimidinebased chemotherapy accord approved Hungarian Summary Product Characteristics Patients suitable Avastin treatment assess treat physician Any contraindication Avastin treatment accord Hungarian Summary Product Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>